PREFERENTIAL SYNTHESIS OF VIRAL LATE RNA BY NUCLEI ISOLATED FROM SV40 LYTICALLY INFECTED CELLSGILBOA E; AVIV H.1976; CELL; U.S.A.; DA. 1976; VOL. 7; NO 4; PP. 567-573; BIBL. 37 REF.Article

How tumors escape immune destruction and what we can do about itGILBOA, E.Cancer immunology and immunotherapy. 1999, Vol 48, Num 7, pp 382-385, issn 0340-7004Conference Paper

Studying the Middle East Conflict by SimulationGILBOA, E.International Journal of Political Education Amsterdam. 1979, Vol 2, Num 2, pp 169-185Article

METHYLATION AND CAPPING OF RNA POLYMERASE II PRIMARY TRANSCRIPTS BY HELA NUCLEAR HOMOGENATES.GRONER Y; GILBOA E; AVIV H et al.1978; BIOCHEMISTRY; U.S.A.; DA. 1978; VOL. 17; NO 6; PP. 977-982; BIBL. 42 REF.Article

PURIFICATION OF SV-40 MESSENGER RNA BY HYBRIDIZATION TO SV-40 DNA COVALENTLY BOUND TO SEPHAROSE.GILBOA E; PRIVES CL; AVIN H et al.1975; BIOCHEMISTRY; U.S.A.; DA. 1975; VOL. 14; NO 19; PP. 4215-4220; BIBL. 45 REF.Article

INITIATION OF RNA SYNTHESIS IN ISOLATED NUCLEI.GILBOA E; SOREQ H; AVIV H et al.1977; EUROP. J. BIOCHEM.; GERM.; DA. 1977; VOL. 77; NO 2; PP. 393-400; BIBL. 20 REF.Article

STRUCTURE OF THE ABELSON MURINE LEUKEMIA VIRUS GENOME AND THE HOMOLOGOUS CELLULAR GENE: STUDIES WITH CLONED VIRAL DNAGOFF SP; GILBOA E; WITTE ON et al.1980; CELL (CAMB.); ISSN 0092-8674; USA; DA. 1980; VOL. 22; NO 3; PP. 777-785; BIBL. 37 REF.Article

Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatmentVIEWEG, J; GILBOA, E.Cancer investigation. 1995, Vol 13, Num 2, pp 193-201, issn 0735-7907Article

Significance of DNase I-hypersensitive sites in the long terminal repeats of a Moloney murine leukemia virus vectorRASMUSSEN, J. A; GILBOA, E.Journal of virology. 1987, Vol 61, Num 5, pp 1368-1374, issn 0022-538XArticle

Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNAVON RÜDEN, T; GILBOA, E.Journal of virology. 1989, Vol 63, Num 2, pp 677-682, issn 0022-538XArticle

CONSTRUCTION OF MAMMALIAN TRANSDUCING VECTOR FROM THE GENOME OF MOLONEY MURINE LEUKEMIA VIRUSGILBOA E; KOLBE M; NOONAN K et al.1982; J. VIROL.; ISSN 0022-538X; USA; DA. 1982; VOL. 44; NO 3; PP. 845-851; BIBL. 39 REF.Article

SYNTHESIS OF A 600-NUCLEOTIDE-LONG PLUS-STRAND DNA BY VIRIONS OF MOLONEY MURINE LEUKEMIA VIRUSMITRA SW; GOFF S; GILBOA E et al.1979; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1979; VOL. 76; NO 9; PP. 4355-4359; BIBL. 56 REF.Article

CELL-FREE TRANSLATION OF SIMIAN VIRUS 40 EARLY MESSENGER RNA CODING FOR VIRAL T-ANTIGEN.PRIVES C; GILBOA E; REVEL M et al.1977; PROC NATION. ACAD. SCI., U.S.A.; U.S.A.; DA. 1977; VOL. 74; NO 2; PP. 457-461; BIBL. 39 REF.Article

Intermediate Bronze Age Tombs at HorshimGILBOA, E; YANNAI, E.Atiqot (1991). 1992, Vol 21, pp 1-8Article

GENOME STRUCTURE OF ABELSON MURINE LEUKEMIA VIRUS VARIANTS: PROVIRUSES IN FIBROBLASTS AND LYMPHOID CELLSGOFF SP; WITTE ON; GILBOA E et al.1981; J. VIROL.; ISSN 0022-538X; USA; DA. 1981; VOL. 38; NO 2; PP. 460-468; BIBL. 25 REF.Article

STRUCTURE OF A CLONED CIRCULAR MOLONEY MURINE LEUKEMIA VIRUS DNA MOLECULE CONTAINING AN INVERTED SEGMENT: IMPLICATIONS FOR RETROVIRUS INTEGRATIONSHOEMAKER C; GOFF S; GILBOA E et al.1980; PROC. NATL. ACAD. SCI.; ISSN 0027-8424; USA; DA. 1980; VOL. 77; NO 7; PP. 3932-3936; BIBL. 41 REF.Article

IN VITRO SYNTHESIS OF A 9KBP TERMINALLY REDUNDANT DNA CARRYING THE INFECTIVITY OF MOLONEY MURINE LEUKEMIA VIRUSGILBOA E; GOFF S; SHIELDS A et al.1979; CELL; USA; DA. 1979; VOL. 16; NO 4; PP. 863-874; BIBL. 25 REF.Article

Immunotherapy of cancer with dendritic-cell-based vaccines : Tumor and dendritic cells as cellular vaccines: confrontation and perspecives: a symposium in writingGILBOA, E; NAIR, S. K; LYERLY, H. K et al.Cancer immunology and immunotherapy. 1998, Vol 46, Num 2, pp 82-87, issn 0340-7004Article

A frameshift mutation at the NH₂ terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopesFETTEN, J. V; ROY, N; GILBOA, E et al.The Journal of immunology (1950). 1991, Vol 147, Num 8, pp 2697-2705, issn 0022-1767Article

Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection = L'expression des gènes introduits dans les cellules par infection rétrovirale est plus efficace que celle des gènes introduits dans les cellules par transfection du DNALIH-HWA SHERRY HWANG; GILBOA, E.Journal of virology. 1984, Vol 50, Num 2, pp 417-424, issn 0022-538XArticle

Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase = Mécanisme de l'élimination de l'amorce d'ARN par l'activité RNAase H de la transcriptase reverse du virus de la myéloblastose aviaireCHAMPOUX, J. J; GILBOA, E; BALTIMORE, D et al.Journal of virology. 1984, Vol 49, Num 3, pp 686-691, issn 0022-538XArticle

Immunotherapy of cancer with genetically modified tumor vaccinesGILBOA, E.Seminars in oncology. 1996, Vol 23, Num 1, pp 101-107, issn 0093-7754Article

Isolation of embryonal carcinoma cell lines that express integrated recombinant genes flanked by the moloney murine leukemia virus long terminal repeatTAKETO, M; GILBOA, E; SHERMAN, M. I et al.Proceedings of the National Academy of Sciences of the United States of America. 1985, Vol 82, Num 8, pp 2422-2426, issn 0027-8424Article

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extractsNAIR, S. K; SNYDER, D; ROUSE, B. T et al.International journal of cancer. 1997, Vol 70, Num 6, pp 706-715, issn 0020-7136Article

Ruminative response style and vulnerability to episodes of dysphoria : Gender, neuroticism, and episode durationROBERTS, J. E; GILBOA, E; GOTLIB, I. H et al.Cognitive therapy and research. 1998, Vol 22, Num 4, pp 401-423, issn 0147-5916Article